Lymphoma Experience

3

1.1K

Lymphoma Experience retweetledi

Maria merida@maolga28·16h

Medicina de Precisión en Linfoma #LEx2026 @LymphomaEx

Español

2

8

419

Lymphoma Experience@LymphomaEx·16h

Sábado para valientes en #LEx2026. @iHematologo introduce el bloque invitado. ¡Medicina de presición en Linfomas!

Español

3

16

282

Lymphoma Experience retweetledi

Eddie Cliff@Eddie_Cliff·2d

Huge & urgent challenges in access in Latin America to overcome here - thanks for highlighting @ASkarbnik Multipronged strategies needed for each class of diagnostics and drugs

In the US we argue CAR-T vs bispecifics while 36% of Latin America fights for access to rituximab. Let that sink in. GELL Survey 2025 — 73 centers, 16 countries: 73% highly restricted access to bispecifics ~0% commercial CAR-T outside Brazil Only 15% have NGS Only 35% access to clinical trials We’re having 2026 debates with early 2000s access. The real question isn’t CAR-T vs bispecifics. It’s: how do we close this gap? Sobering data presented by @DrMCanales here in Chile. @LymphomaEx Colunga-Pedraza et al. Blood 2025;146(Suppl 1):6193 #Lymphoma #DLBCL #LATAM #GlobalOncology #HealthEquity

English

3

12

1.2K

Lymphoma Experience retweetledi

Matthew Cortese, MD, MPH@Matt_Cortese·2d

Definitely a call to action to expand access for advanced treatments throughout the world and find more efficient ways to help patients globally. Thanks for sharing Dr. @ASkarbnik

In the US we argue CAR-T vs bispecifics while 36% of Latin America fights for access to rituximab. Let that sink in. GELL Survey 2025 — 73 centers, 16 countries: 73% highly restricted access to bispecifics ~0% commercial CAR-T outside Brazil Only 15% have NGS Only 35% access to clinical trials We’re having 2026 debates with early 2000s access. The real question isn’t CAR-T vs bispecifics. It’s: how do we close this gap? Sobering data presented by @DrMCanales here in Chile. @LymphomaEx Colunga-Pedraza et al. Blood 2025;146(Suppl 1):6193 #Lymphoma #DLBCL #LATAM #GlobalOncology #HealthEquity

English

2

7

392

Lymphoma Experience retweetledi

Laura Korin@laura_korin·1d

Invicta en los debates de @LymphomaEx! En esta oportunidad defendiendo el uso de drogas target en el tto del linfoma t r/r. Otra vez será @HemSandoval!

Español

2

11

352

Lymphoma Experience retweetledi

Guilherme Perini, MD@GuiperiniMD·2d

Thanks for highlighting this important survey from @Grupo_GELL. That is the reason I believe research is so important in our region. Until we fix our broken system, research saves lives.

In the US we argue CAR-T vs bispecifics while 36% of Latin America fights for access to rituximab. Let that sink in. GELL Survey 2025 — 73 centers, 16 countries: 73% highly restricted access to bispecifics ~0% commercial CAR-T outside Brazil Only 15% have NGS Only 35% access to clinical trials We’re having 2026 debates with early 2000s access. The real question isn’t CAR-T vs bispecifics. It’s: how do we close this gap? Sobering data presented by @DrMCanales here in Chile. @LymphomaEx Colunga-Pedraza et al. Blood 2025;146(Suppl 1):6193 #Lymphoma #DLBCL #LATAM #GlobalOncology #HealthEquity

English

4

17

1.1K

Lymphoma Experience retweetledi

Alan Skarbnik@ASkarbnik·2d

Las discusiones más productivas sobre linfoma no ocurren en el podio… ocurren en la cervecería. 🍺 Seguimos debatiendo, pero ahora con mejor hidratación. 😏 #Lymphoma #HematologyLife #Chile

Español

Lymphoma Experience@LymphomaEx

5

26

1.9K

Lymphoma Experience retweetledi

Joaquín Díaz-Schmidt@iHematologo·1d

Wisdom

“Searching for the ideal partner” (Venetoclax in CLL) Brillante @silcugliari Sólo en #LEx26

English

1

9

360

Lymphoma Experience@LymphomaEx·1d

“Searching for the ideal partner” (Venetoclax in CLL) Brillante @silcugliari Sólo en #LEx26

Español

2

14

923

Lymphoma Experience@LymphomaEx·2d

@Matt_Cortese @ASkarbnik @GuiperiniMD @iHematologo There is also fun involved!

English

1

26

Matthew Cortese, MD, MPH@Matt_Cortese·2d

@ASkarbnik @GuiperiniMD @LymphomaEx @iHematologo Looks like a very important but very serious meeting

English

0

3

129

Lymphoma Experience retweetledi

Alan Skarbnik@ASkarbnik·2d

La conferencia comenzó con una gran conversación para intentar establecer las mejores prácticas para el tratamiento de linfomas y LLC en Latinoamérica. #Lymphoma @LymphomaEx @GuiperiniMD @iHematologo

Español

5

18

810

Lymphoma Experience@LymphomaEx·2d

Nada como activar un poco el networking con un café entre simposios. #LEx26

Español

1

6

358

Lymphoma Experience@LymphomaEx·2d

Junto a nuestro expositores discutiendo LExACT 2026 comienza #LEx26

Español

4

13

477

Lymphoma Experience@LymphomaEx·4d

Welcome back!

🇨🇱 Chile -bound this week for @LymphomaEx conference to learn from some of the top lymphoma experts in Latin America. Excited to exchange ideas on how we’re advancing CLL and lymphoma care across borders. And of course, looking forward to some Asado, karaoke with @GuiperiniMD (as well as a surprise debate), amazing views and great friends. Thank you for the invitation @cytohance @nico30f @iHematologo 🇨🇱🇧🇷🇺🇸

English

1

201

Lymphoma Experience@LymphomaEx·12 Mar

Una semana para #LEx26. Nos vemos en Puerto Varas. lexmeet.org

Español